Philip L Johnson Jazz Pharmaceuticals PLC (JAZZ) insider trading activity
Philip L Johnson is EVP & Chief Financial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 27,932 shares of JAZZ, which is worth approximately $3.5 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 12,000 shares (Ordinary Shares) at a price of $119.65 per share, resulting in proceeds of $1,435,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
27.9K
0%
3M change
n/a
12M change
Total Value Held
$3.5 Million
Philip L Johnson Transaction History
PLJ
Philip L Johnson
EVP & Chief Financial Officer
Dublin 4, L2